Literature DB >> 33484041

Redefining the Treatment Endpoints in Oncology.

Pallvi Kaul1, Pankaj Kumar Garg1.   

Abstract

Year:  2021        PMID： 33484041      PMCID： PMC7930423          DOI： 10.1002/onco.13688

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  3 in total

1.  New cancer drugs at the cost of bankruptcy: will the oncologist tell the patients the benefit in terms of days/weeks added to life?

Authors:  Pankaj Kumar Garg; Bhupendra Kumar Jain
Journal:  Oncologist       Date:  2014-12

2.  Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.

Authors:  Joel Shapiro; J Jan B van Lanschot; Maarten C C M Hulshof; Pieter van Hagen; Mark I van Berge Henegouwen; Bas P L Wijnhoven; Hanneke W M van Laarhoven; Grard A P Nieuwenhuijzen; Geke A P Hospers; Johannes J Bonenkamp; Miguel A Cuesta; Reinoud J B Blaisse; Olivier R C Busch; Fiebo J W Ten Kate; Geert-Jan M Creemers; Cornelis J A Punt; John Th M Plukker; Henk M W Verheul; Ernst J Spillenaar Bilgen; Herman van Dekken; Maurice J C van der Sangen; Tom Rozema; Katharina Biermann; Jannet C Beukema; Anna H M Piet; Caroline M van Rij; Janny G Reinders; Hugo W Tilanus; Ewout W Steyerberg; Ate van der Gaast
Journal:  Lancet Oncol       Date:  2015-08-05       Impact factor: 41.316

3.  Patients' Understanding of Oncology Clinical Endpoints: Environmental Scan and Focus Groups.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Kate Ferriola-Bruckenstein; Janice P Tzeng; Vanessa Boudewyns
Journal:  Oncologist       Date:  2020-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.